NasdaqCM - Delayed Quote USD
Tempest Therapeutics, Inc. (TPST)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 7:58 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 4 | 5 |
| Avg. Estimate | -0.36 | -0.35 | -1.5 | -1.38 |
| Low Estimate | -0.4 | -0.42 | -1.59 | -1.81 |
| High Estimate | -0.31 | -0.27 | -1.42 | -0.62 |
| Year Ago EPS | -0.48 | -0.38 | -1.91 | -1.5 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.57 | -0.39 | -0.37 | -0.4 |
| EPS Actual | -0.48 | -0.38 | -0.36 | -0.42 |
| Difference | 0.09 | 0.01 | 0.01 | -0.02 |
| Surprise % | 15.80% | 2.60% | 2.70% | -5.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.36 | -0.35 | -1.5 | -1.38 |
| 7 Days Ago | -0.36 | -0.35 | -1.5 | -1.38 |
| 30 Days Ago | -0.35 | -0.37 | -1.52 | -1.57 |
| 60 Days Ago | -0.35 | -0.37 | -1.52 | -1.57 |
| 90 Days Ago | -0.35 | -0.36 | -1.36 | -1.54 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| CURRENCY IN USD | TPST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.00% | -- | -- | 3.80% |
| Next Qtr. | 7.90% | -- | -- | 8.00% |
| Current Year | 21.50% | -- | -- | 2.50% |
| Next Year | 8.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 6/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/10/2024 |
Related Tickers
TVGN Tevogen Bio Holdings Inc.
1.7200
+24.64%
BDRX Biodexa Pharmaceuticals Plc
5.70
-2.90%
ATNF 180 Life Sciences Corp.
5.03
+16.17%
ADTX Aditxt, Inc.
1.0500
-2.78%
QNRX Quoin Pharmaceuticals, Ltd.
0.8500
+28.79%
MTEM Molecular Templates, Inc.
0.7500
-19.35%
RANI Rani Therapeutics Holdings, Inc.
2.6800
+1.90%
DRUG Bright Minds Biosciences Inc.
47.21
+117.56%
WVE Wave Life Sciences Ltd.
15.31
+4.79%
SEEL Seelos Therapeutics, Inc.
1.2800
0.00%